Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.

@article{Wu2002PlasmaVE,
  title={Plasma vascular endothelial growth factor is useful in assessing progression of breast cancer post surgery and during adjuvant treatment.},
  author={Y. Wu and L. Salda{\~n}a and R. Chillar and J. Vadgama},
  journal={International journal of oncology},
  year={2002},
  volume={20 3},
  pages={
          509-16
        }
}
Vascular endothelial growth factor (VEGF) has been shown to induce angiogenesis in vivo and in vitro. However, the association of plasma VEGF with tumor histopathology in high risk groups such as African American and non-white Hispanic women with breast cancer is not well understood. There is limited information on the prognostic relevance of plasma VEGF in patients who have had surgery and adjuvant treatment for breast cancer. In this study, we measured plasma VEGF from 125 minority women with… Expand

Paper Mentions

Interventional Clinical Trial
Primary Operation in synchronous metastasized invasive breast cancer to evaluate the use of local therapy  
ConditionsCirculating Tumor Cells, Synchronous Metastasized Breast Cancer
InterventionProcedure
Vascular endothelial growth factor and breast cancer risk
The influence of fractionated radiation therapy on plasma vascular endothelial growth factor (VEGF) concentration in dogs with spontaneous tumors and its impact on outcome.
...
1
2
3
4
5
...